Company news

Nuwellis, Inc. news in 2024

Nuwellis, Inc.'s news releases, calls and decks from 2024, newest first.

View company

Nuwellis, Inc. Announces Third Quarter 2024 Financial Results and Recent Highlights

November 10, 2024

Nuwellis Announces Exercise of Warrants for $5.1 Million of Gross Proceeds

November 4, 2024

Nuwellis Receives Increased Reimbursement Rate for Aquadex SmartFlow® Therapy from the Centers for Medicare and Medicaid

November 3, 2024

Nuwellis Announces Preliminary Results for Third Quarter of 2024

October 31, 2024

Nuwellis Welcomes University of Iowa Health Care Stead Family Children’s Hospital as Newest Pediatric Customer

October 30, 2024

Nuwellis, Inc. To Report Third Quarter 2024 Financial Results on November 11, 2024

October 22, 2024

Nuwellis Announces Pricing of $916,000 Registered Direct Offering Priced At-The-Market Under Nasdaq Rules

August 22, 2024

Nuwellis, Inc. Announces Second Quarter 2024 Financial Results

August 12, 2024

Nuwellis Announces First Pediatric Patient Treated in a Commercial Setting with SeaStar Medical’s QUELIMMUNE™ Therapy at Cincinnati Children’s

July 25, 2024

Nuwellis Announces Pricing of $2.0 Million Offering Priced At-The-Market Under Nasdaq Rules

July 23, 2024

Nuwellis Marks First Commercial Sale of QUELIMMUNE™ Therapy to Cincinnati Children’s

July 16, 2024

Nuwellis Announces Reverse Stock Split

June 25, 2024

Nuwellis Secures New Patent for Innovative Pediatric Continuous Renal Replacement Therapy, Vivian™

June 24, 2024

Nuwellis and DaVita Extend Supply and Collaboration Agreement Pilot Phase

June 5, 2024

Nuwellis Announces Expansion of Ultrafiltration Program to Pediatric Patients at One of the Largest Hospital Networks in Florida

May 13, 2024

Nuwellis Announces Purchase Agreement with a 50 Hospital Network for Aquadex Ultrafiltration Therapy

May 8, 2024

Nuwellis, Inc. Announces First Quarter 2024 Financial Results

May 6, 2024

Nuwellis Receives USPTO Notice of Patent Allowance for Innovative Pediatric CRRT Technology

May 1, 2024

Nuwellis, Inc. To Report First Quarter 2024 Financial Results on May 7, 2024

April 29, 2024

Nuwellis Announces Closing of $2.7 Million Public Offering

April 29, 2024

Nuwellis Announces Pricing of $2.7 Million Public Offering

April 25, 2024

Nuwellis Announces Launch of Ultrafiltration Therapy Using Aquadex Smartflow® System at Henry Ford Health

April 8, 2024

Nuwellis, Inc. Announces Fourth Quarter and Full Year 2023 Financial Results

March 4, 2024

Nuwellis, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

February 19, 2024

Nuwellis Receives FDA Clearance for an Additional Dual Lumen Extended Length Peripheral Catheter

January 3, 2024

Calls in 2024

Decks in 2024